Major new initiative will add AI to ³Ô¹Ï±¬ÁÏ applications and the ³Ô¹Ï±¬ÁÏ Vault Platform to help automate
critical industry-specific functions and improve productivity from clinical to commercial<\/i><\/p>\n
BARCELONA, Spain \u2014 29 April 2025 \u2014 <\/strong> ³Ô¹Ï±¬ÁÏ Systems<\/a> (NYSE: VEEV) today announced ³Ô¹Ï±¬ÁÏ AI<\/a>, a major new initiative that adds AI to the ³Ô¹Ï±¬ÁÏ Vault Platform and ³Ô¹Ï±¬ÁÏ applications to help life sciences companies automate tasks and improve employee productivity using AI Agents and AI Shortcuts. ³Ô¹Ï±¬ÁÏ AI provides a fast and efficient way to introduce application-specific AI Agents based on large language models (LLMs) into existing ³Ô¹Ï±¬ÁÏ applications and enable end users with AI Shortcuts. ³Ô¹Ï±¬ÁÏ AI will work in all ³Ô¹Ï±¬ÁÏ applications across all major areas, including clinical, regulatory, safety, quality, medical, and commercial.<\/p>\n ³Ô¹Ï±¬ÁÏ AI Agents can be deployed quickly with high impact because they understand the ³Ô¹Ï±¬ÁÏ application context, have application-specific prompts and safeguards, and have direct, secure access to ³Ô¹Ï±¬ÁÏ application data, documents, and workflows. Customers can configure and extend ³Ô¹Ï±¬ÁÏ-delivered AI Agents and build custom AI Agents to address company-specific use cases. AI Agents can be used through a chatbot user interface or called via the AI API.<\/p>\n ³Ô¹Ï±¬ÁÏ AI Shortcuts empower end users with the ability to easily set up personal AI-powered automations to accomplish frequent user-specific tasks such as helping with workflows, generating insights, or researching a topic.<\/p>\n \u201cGenAI is a new computing paradigm that will significantly increase productivity for knowledge workers,\u201d said ³Ô¹Ï±¬ÁÏ CEO Peter Gassner. \u201cCore applications give you structured data, business rules and workflow. They execute with the speed, consistency, and scale we expect from computers. GenAI brings the more human-like ability to derive answers and insights from ambiguous situations that deal with language, context, and broad-based knowledge. Core applications and GenAI working seamlessly together will bring significant productivity gains.\u201d<\/p>\n ³Ô¹Ï±¬ÁÏ AI is LLM agnostic and will support most major large language models. Customers may use a ³Ô¹Ï±¬ÁÏ-supplied LLM or configure ³Ô¹Ï±¬ÁÏ AI to use a customer-specific LLM. Regardless of deployment or which LLM is used by a customer, ³Ô¹Ï±¬ÁÏ AI keeps customer data secure for each customer.<\/p>\n \u201cOur customers depend on ³Ô¹Ï±¬ÁÏ applications for some of their most critical industry-specific processes from clinical to commercial. They want to use AI to improve productivity and ultimately get treatments to patients faster,\u201d said CEO Peter Gassner. \u201cAdding ³Ô¹Ï±¬ÁÏ AI to our core applications will help make AI simple, secure, and compliant for life sciences companies of all sizes.\u201d<\/p>\n The first release of ³Ô¹Ï±¬ÁÏ AI is planned for December 2025 and will be licensed at the Vault level with a simple and reasonable subscription fee to encourage industry adoption that is both broad and thoughtful.<\/p>\n About ³Ô¹Ï±¬ÁÏ Systems<\/strong> ³Ô¹Ï±¬ÁÏ Forward-looking Statements<\/strong> ###<\/center><\/p>\n
\n³Ô¹Ï±¬ÁÏ is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,000 customers, ranging from the world\u2019s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation<\/a>, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.<\/p>\n
\nThis release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ\u2019s products and services and the expected results or benefits from use of our products and services, including certain of our new solutions and applications that are still under development or not generally available. These statements are based on our current expectations. Actual results, availability, and any future events relating to these products and services could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended January 31, 2025, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 9 and 10), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.<\/p>\n